SCHEMBL21376314

SCHEMBL21376314

CN(Sc1ccc(C(=O)O)cc1)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SRD5A2 P31213 4/20 0.54
▸ EPHX2 P34913 1/20 0.44
▸ CYP2C8 P10632 1/20 0.43
▸ CES2 O00748 1/20 0.43
▸ CES1 P23141 1/20 0.43
▸ RXRA P19793 1/20 0.43
▸ RXRB P28702 1/20 0.43
▸ RXRG P48443 1/20 0.43
▸ NR4A1 P22736 1/20 0.42
▸ NR4A2 P43354 1/20 0.42
▸ NR4A3 Q92570 1/20 0.42
▸ NPC1 O15118 2/20 0.40
▸ LTC4S Q16873 2/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ PTPN1 P18031 2/20 0.39
▸ MAP4K4 O95819 1/20 0.39
▸ GSK3B P49841 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21376794 0.84 BCL2L1 (0.52) CES2CES1NR4A2NPC1RAB9A
SCHEMBL21376318 0.81 TSHR (0.45) SRD5A2CES2CES1NPC1RAB9A
SCHEMBL21376506 0.80 TSHR (0.55) SRD5A2RXRARXRBNR4A2NPC1
SCHEMBL21376784 0.78 CA1 (0.61) CES2CES1RXRANPC1RAB9A
Ethane SCHEMBL10971565 0.77 SRD5A2 (0.80) SRD5A2EPHX2CYP2C8CES2CES1
SCHEMBL78879 0.77 SRD5A2 (0.87) SRD5A2EPHX2CYP2C8CES2CES1
SCHEMBL1330891 0.77 SRD5A2 (0.87) SRD5A2EPHX2CYP2C8CES2CES1
SCHEMBL23521062 0.75 SRD5A2 (0.83) SRD5A2EPHX2CYP2C8CES2CES1
SCHEMBL6762584 0.75 SRD5A2 (0.83) SRD5A2EPHX2CYP2C8CES2CES1
SCHEMBL1042428 0.75 SRD5A2 (0.83) SRD5A2EPHX2CYP2C8CES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3626240-A1 PROCESS OF PREPARATION OF A N-ARYL BENZYL SULFONAMIDE SUBSTITUTED WITH AN AMIDO GROUP StemSynergy Therapeutics, Inc. (US) 2020-03-25 — — EP disclosed
EP-2403499-B1 METHODS AND COMPOSITIONS FOR USE IN TREATING CANCER AND REDUCING WNT MEDIATED EFFECTS IN A CELL STEMSYNERGY THERAPEUTICS INC (US) 2019-09-18 — — EP disclosed
Send feedback